Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 Study in Subjects With Tumours Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ADIPemCis) (TRAP Study)

Trial Profile

Phase 1 Study in Subjects With Tumours Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ADIPemCis) (TRAP Study)

Status: Discontinued
Phase of Trial: Phase I

Latest Information Update: 07 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cisplatin (Primary) ; Pegargiminase (Primary) ; Pemetrexed (Primary) ; Folic acid
  • Indications Glioma; Liver cancer; Malignant-mesothelioma; Non-small cell lung cancer; Uveal melanoma
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms TRAP
  • Sponsors Polaris Pharmaceuticals
  • Most Recent Events

    • 03 Mar 2020 Status changed from active, no longer recruiting to discontinued.
    • 04 Jun 2019 Results (n=21) assessing dose-expansion study in patients with argininosuccinate syntherase 1 deficinent non-small cell lung cancer presented at the 55th Annual Meeting of the American Society of Clinical Oncology
    • 18 Mar 2019 Planned End Date changed from 1 Feb 2019 to 1 May 2020.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top